Back to resultsStudies of the Immune Response in Normal Subjects and Patients With Disorders of the Immune System
Primary Purpose
Immunologic Deficiency Syndromes, Neoplasms
Status
Completed
Phase
Locations
United States
Study Type
Observational
Intervention
Sponsored by
About this trial
This is an observational trial for Immunologic Deficiency Syndromes focused on measuring Cellular Immunity, Humoral Immunity, Immunodeficiency Disease
Eligibility Criteria
Patients will be studied if a disorder of the immune system is suspected.
Sites / Locations
- National Cancer Institute (NCI)
Outcomes
Primary Outcome Measures
Secondary Outcome Measures
Full Information
NCT ID
NCT00001158
First Posted
November 3, 1999
Last Updated
March 4, 2008
Sponsor
National Cancer Institute (NCI)
1. Study Identification
Unique Protocol Identification Number
NCT00001158
Brief Title
Studies of the Immune Response in Normal Subjects and Patients With Disorders of the Immune System
Official Title
Studies of the Immune Response in Normal Subjects and Patients With Disorders of the Immune System
Study Type
Observational
2. Study Status
Record Verification Date
April 1999
Overall Recruitment Status
Completed
Study Start Date
April 1977 (undefined)
Primary Completion Date
undefined (undefined)
Study Completion Date
March 2000 (undefined)
3. Sponsor/Collaborators
Name of the Sponsor
National Cancer Institute (NCI)
4. Oversight
5. Study Description
Brief Summary
The goal of the protocol is to define the normal humoral and cellular immune responses to antigens in volunteers and to define abnormalities of these immune responses in patients with immunodeficiency diseases or cancer. In vitro assays and in vivo skin tests and immunization with antigens will be utilized.
Detailed Description
The goal of the protocol is to define the normal humoral and cellular immune responses to antigens in volunteers and to define abnormalities of these immune responses in patients with immunodeficiency diseases or cancer. In vitro assays and in vivo skin tests and immunization with antigens will be utilized.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Immunologic Deficiency Syndromes, Neoplasms
Keywords
Cellular Immunity, Humoral Immunity, Immunodeficiency Disease
7. Study Design
10. Eligibility
Sex
All
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Patients will be studied if a disorder of the immune system is suspected.
Facility Information:
Facility Name
National Cancer Institute (NCI)
City
Bethesda
State/Province
Maryland
ZIP/Postal Code
20892
Country
United States
12. IPD Sharing Statement
Citations:
PubMed Identifier
1127501
Citation
Nelson DL, Blaese RM, Strober W, Bruce R, Waldmann TA. Constrictive pericarditis, intestinal lymphangiectasia, and reversible immunologic deficiency. J Pediatr. 1975 Apr;86(4):548-54. doi: 10.1016/s0022-3476(75)80145-4.
Results Reference
background
Learn more about this trial
Studies of the Immune Response in Normal Subjects and Patients With Disorders of the Immune System
We'll reach out to this number within 24 hrs